SI9420001B - Polipeptidni antagonisti bombezina - Google Patents
Polipeptidni antagonisti bombezina Download PDFInfo
- Publication number
- SI9420001B SI9420001B SI9420001A SI9420001A SI9420001B SI 9420001 B SI9420001 B SI 9420001B SI 9420001 A SI9420001 A SI 9420001A SI 9420001 A SI9420001 A SI 9420001A SI 9420001 B SI9420001 B SI 9420001B
- Authority
- SI
- Slovenia
- Prior art keywords
- alkyl
- phenyl
- hydrogen
- peptide
- moiety
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- C07K7/086—Bombesin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
Claims (14)
- PATENTNI ZAHTEVKI 1. Bombezinski antagonistični peptid s formulo: X-A1-Az-Trp-Ala-Val-Gly-His-Leu-psi-A9-Q kjer je X vodik, enojna vez, ki veže alfa amino skupino A1 na gama karboksilni delež na 3-propionilnem deležu A2, če je A2 Glu[-], ali skupina s formulo R'CO-, kjer R1 izberemo izmed skupin, ki j ih sestavljajo a) vodik, Cj 10-alkil, fenil, fenil-Cj ]0-alkil, p-HI-fentl, p-HI-fenil-Cj 10-alkil, naftil, naftil-Cj 10-alkil, indolil, indolil-Cj 10-alkil, piridil, piridil-Cj 10-alkil, tienil, tienil-Cj 10-alkil, cikloheksil ali cikloheksil-Cj 10-alkil, kjer je HI = F, Cl, Br, OH, CH3 ali OCH^ b) R2 R3 > N— kjer je R2 vodik, Cj 10-alkil, fenil ali fenil-Cj 10-alkil, R3 je vodik ali C1_10-alkil; c) R4-0, kjer je R4 Cj 10-alkil, fenil ali fenil-CM0-alkil; A1 je D- ali L-amino kislinski ostanek, izbran iz skupine, ki jo sestavljajo Phe, p-HI-Phe, pGlu, Nal, Pal, Tpi, nesubstituiran Trp ali Trp substituiran v benzenskem obroču z enim ali več členi, izbranimi iz skupine, ki jo sestavljajo F, Cl, Br, NH2 ali C13-alkil; ali peptidna vez, ki veže acilni delež R^O na alfa amino delež A2, pod pogojem, da je X = R^O; A2 je Gin, Glu [-], Glu (Y), ali His, kjer je [-] enojna vez, če je X enojna vez in je A2 Glu[-], pri čemer [-] veže gama 1 z karboksilni delež na 3-propionilnem deležu A2 z alfa amino skupino A1, Y je a) -OR5, kjer je R5 vodik, Cj 3-alkil ali fenil; ali b) R6 — N R7 kjer je R6 vodik ali Cj 3-alkil; R7 je vodik, 3-alkil ali -NHCONl·^ in je Leu-psi- reducirana oblika Leu, kjer je C = O delež namesto -CLtako da je vez tega -CRj- deleža z alfa amino deležem sosednjega A9 ostanka psevdopeptidna vez; A9 je Tac, MTac, ali DMTac; in Q je NH2 ali -OO1, kjer je O1 vodik, C]!0-alkil, fenil ali fenil-Cj 10-alkil; in njegove farmacevtsko sprejemljive kisline ali soli.
- 2. Peptid po zahtevku 1, označen s tem, da je X = vodik ali R^O, kjer je R = H ali C310-alkil; A1 je D-Cpa, D-Nal, L- ali D-Pal, D-Phe, L- ali D-Tpi, ali D-Trp; A2 je Gin ali His; in Q je NH^.
- 3. Peptid po zahtevku 2, označen s tem, da je A9 Tac.
- 4. Peptid po zahtevku 2, označen s tem, da je A9 DMTac.
- 5. Peptid po zahtevku 3, označen s tem, da je X vodik ali Ac, A1 je D-Phe, L- ali D-Tpi, in A2 je Gin.
- 6. Peptid po zahtevku 4, označen s tem, da je X vodik ali Ac, A1 je D-Phe, L- ali D-Tpi, in A2 je Gin. 3 3
- 7. Peptid po zahtevku 3 s formulo sekv.id.št.2 D-Phe-Gln-Trp-Ala-Val-Glv-His-Leu-psi-Tac-NH-.·
- 8. Peptid po zahtevku 3 s formulo sekv.id.št.13 D-Tpi-Gln-Trp-Ala-Val-Glv-His-Leu-psi-Tac-NI-L,·
- 9. Peptid po zahtevku 4 s formulo sekv.id.št.18 D-Phe-Gln-Trp-Ala-Val-Glv-His-Leu-psi-DMTac-NH^.
- 10. Bombezinskj antagonistični peptid s formulo: X-A1-A2-Trp-Ala-Val-Glv-His-Leu-psi-A9-Q kjer je X vodik, enojna vez, ki veže alfa amino skupino A1 na gama karboksilni delež na 3-propionilnem deležu A2, če je A2 = Glu[-]; ali skupina s formulo R^CO-, kjer R1 izberemo izmed skupin, ki jih sestavljajo a) vodik, CM0-alkil, fenil ali fenil-C, 10-alkil; b) R2N— kjer je R2 vodik, Cj 10-alkil, fenil ali fenil-CM0-alkil, R3 je vodik ali CM0-alkil; c) R4-0, kjer je R4 = CM0-alkil, fenil ali fenil-Cj 10-alkil; A1 je nenaravna amino kislina, izbrana iz skupine, ki jo sestavljajo L- ali D-Pal ali L-ali D-Tpi; A2 je Gin, Glu [-], Glu (Y) ali His, kjer je [-] enojna vez, če je X enojna vez in je A2 Glu[-], pri čemer [-] veže gama karboksilni delež na 3-propionilnem deležu A2 z alfa amino skupino A1, Yje a) -OR5, kjer je R5 vodik, Cj 3-alkil ali fenil; b) R6kjer je R6 vodik ali C5 3-alkil; R7 je vodik, Cj 3-alkil ali -NHCONl·^ in je Leu-psi- reducirana oblika Leu, kjer je C = O delež namesto -CH^-, tako da je vez tega -CH2- deleža z alfa amino skupino sosednjega A9 ostanka psevdopeptidna vez; A9 je Cys ali Pen; in Q je NH2 ali -OQ\ kjer je O1 vodik, CM0-alkil, fenil ali fenil-Cj 10-alkil; in njegove farmacevtsko sprejemljive kisline ali soli.
- 11. Bombezinski antagonistični peptid po zahtevku 1, označen s tem, da je XjeR1CO, A1 je peptidna vez, ki veže acilni delež RjCO- na alfa amino delež A2; A2 je Gin ali His; in Q je NHr
- 12. Peptid po zahtevku 11, označen s tem, da je X = Hca, Hna, Paa, Mpp, Hpp ali Naa, A2 je Gin in A9 je Tac.
- 13. Peptid po zahtevku 12 s formulo sekv.id.št.14 Hca-Gln-Trp-Ala-Val-Gly-His-Leu-psi-Tac-NH2.
- 14. Farmacevtski sestavek, označen s tem, da vsebuje polipeptid po zahtevku 1, njegovo terapevtsko sprejemljivo obliko adicijske soli ali kompleks le-teh in njihov farmacevtsko sprejemljiv tekoč ali trden nosilec.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/031,325 US5369094A (en) | 1990-11-29 | 1993-03-15 | Polypeptide bombesin antagonists |
PCT/US1994/002511 WO1994021674A1 (en) | 1993-03-15 | 1994-03-07 | Polypeptide bombesin antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
SI9420001A SI9420001A (en) | 1995-08-31 |
SI9420001B true SI9420001B (sl) | 1999-08-31 |
Family
ID=21858823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9420001A SI9420001B (sl) | 1993-03-15 | 1994-03-07 | Polipeptidni antagonisti bombezina |
Country Status (27)
Country | Link |
---|---|
US (1) | US5369094A (sl) |
EP (1) | EP0646127B1 (sl) |
JP (1) | JP3838656B2 (sl) |
KR (1) | KR100306506B1 (sl) |
AT (1) | ATE167874T1 (sl) |
AU (1) | AU666270B2 (sl) |
BR (1) | BR9404341A (sl) |
CA (1) | CA2135787C (sl) |
CZ (1) | CZ286750B6 (sl) |
DE (1) | DE69411342T2 (sl) |
DK (1) | DK0646127T3 (sl) |
EE (1) | EE03180B1 (sl) |
ES (1) | ES2120615T3 (sl) |
FI (1) | FI945378A (sl) |
HR (1) | HRP940164B1 (sl) |
HU (1) | HU218288B (sl) |
IL (2) | IL108851A (sl) |
NO (1) | NO313418B1 (sl) |
NZ (2) | NZ299913A (sl) |
PL (1) | PL180372B1 (sl) |
RU (1) | RU2114118C1 (sl) |
SI (1) | SI9420001B (sl) |
SK (1) | SK282267B6 (sl) |
TW (1) | TW325478B (sl) |
UA (1) | UA34456C2 (sl) |
WO (1) | WO1994021674A1 (sl) |
ZA (1) | ZA941767B (sl) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5723578A (en) * | 1987-09-24 | 1998-03-03 | The Administrators Of Tulane Educational Fund | Peptide analogs of bombesin |
US5877277A (en) | 1987-09-24 | 1999-03-02 | Biomeasure, Inc. | Octapeptide bombesin analogs |
US5650395A (en) * | 1995-03-13 | 1997-07-22 | Hurel; Steven | Treatment of pulmonary hypertension |
US6989371B1 (en) | 1996-08-16 | 2006-01-24 | Dabur Research Foundation | Bombesin analogs for treatment of cancer |
US6200546B1 (en) | 1997-04-22 | 2001-03-13 | The Curators Of The University Of Missouri | Gastrin receptor-avid peptide conjugates |
CA2426521A1 (en) * | 2000-11-17 | 2002-05-23 | Warner-Lambert Company Llc | Treatment of sexual dysfunction using bombesin antagonist |
US7226577B2 (en) | 2003-01-13 | 2007-06-05 | Bracco Imaging, S. P. A. | Gastrin releasing peptide compounds |
US7850947B2 (en) | 2003-01-13 | 2010-12-14 | Bracco Imaging S.P.A. | Gastrin releasing peptide compounds |
US20060239923A1 (en) * | 2003-01-13 | 2006-10-26 | Bracco Imaging S.P.A. | Gastrin releasing peptide compounds |
US8420050B2 (en) * | 2003-01-13 | 2013-04-16 | Bracco Imaging S.P.A. | Gastrin releasing peptide compounds |
US7922998B2 (en) * | 2003-01-13 | 2011-04-12 | Bracco Imaging S.P.A. | Gastrin releasing peptide compounds |
ATE435035T1 (de) * | 2003-01-13 | 2009-07-15 | Bracco Imaging Spa | Verbesserte linker für radiopharmazeutische verbindungen |
US7611692B2 (en) * | 2003-01-13 | 2009-11-03 | Bracco Imaging S.P.A. | Gastrin releasing peptide compounds |
JP4578470B2 (ja) | 2003-04-22 | 2010-11-10 | イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ | ソマトスタチンベクター |
US7795385B2 (en) * | 2004-12-17 | 2010-09-14 | Bexar Global, Inc. | Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
FR2918566B1 (fr) * | 2007-07-11 | 2009-10-09 | Pierre Fabre Medicament Sa | Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine. |
EP2100900A1 (en) * | 2008-03-07 | 2009-09-16 | Universitätsspital Basel | Bombesin analog peptide antagonist conjugates |
EP2198878A1 (en) * | 2008-12-18 | 2010-06-23 | University Of Miami | Polypeptide bombesin antagonists |
US8829196B2 (en) | 2009-10-07 | 2014-09-09 | Merck Sharp & Dohme Corp. | TRPA1 antagonists |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5162497A (en) * | 1987-09-24 | 1992-11-10 | The Administrators Of The Tulane Educational Fund | Bradykinin analogs with non-peptide bond |
US5084555A (en) * | 1989-08-21 | 1992-01-28 | The Administrators Of The Tulane Educational Fund | An octapeptide bombesin analog |
JP2795449B2 (ja) * | 1987-09-24 | 1998-09-10 | ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド | 治療用ペプチド |
AU618029B2 (en) * | 1987-11-02 | 1991-12-12 | Imperial Chemical Industries Plc | Polypeptide compounds |
GB8813356D0 (en) * | 1988-06-06 | 1988-07-13 | Ici Plc | Polypeptide compounds |
GR1000608B (el) * | 1988-07-21 | 1992-08-31 | Erba Carlo Spa | Μεθοδος για την παρασκευη ανταγωνιστων bombesin. |
MC2144A1 (fr) * | 1988-10-14 | 1992-02-19 | Univ Tulane | Peptides therapeutiques |
US5217955A (en) * | 1989-09-15 | 1993-06-08 | Biomeasure, Inc. | Treatment of cancer with peptide analog of bombesin, grp, litorin or neuromedin |
US5244883A (en) * | 1990-11-29 | 1993-09-14 | The Administrators Of The Tulane Educational Fund | Nonapeptide bombesin antagonists |
-
1993
- 1993-03-15 US US08/031,325 patent/US5369094A/en not_active Expired - Lifetime
-
1994
- 1994-02-23 TW TW083101048A patent/TW325478B/zh not_active IP Right Cessation
- 1994-03-03 IL IL10885194A patent/IL108851A/xx not_active IP Right Cessation
- 1994-03-07 BR BR9404341-8A patent/BR9404341A/pt not_active Application Discontinuation
- 1994-03-07 WO PCT/US1994/002511 patent/WO1994021674A1/en active IP Right Grant
- 1994-03-07 HU HU9403244A patent/HU218288B/hu not_active IP Right Cessation
- 1994-03-07 JP JP52109194A patent/JP3838656B2/ja not_active Expired - Fee Related
- 1994-03-07 SK SK1364-94A patent/SK282267B6/sk unknown
- 1994-03-07 DK DK94912199T patent/DK0646127T3/da active
- 1994-03-07 EP EP94912199A patent/EP0646127B1/en not_active Expired - Lifetime
- 1994-03-07 CZ CZ19942807A patent/CZ286750B6/cs not_active IP Right Cessation
- 1994-03-07 SI SI9420001A patent/SI9420001B/sl not_active IP Right Cessation
- 1994-03-07 CA CA002135787A patent/CA2135787C/en not_active Expired - Fee Related
- 1994-03-07 KR KR1019940704104A patent/KR100306506B1/ko not_active IP Right Cessation
- 1994-03-07 ES ES94912199T patent/ES2120615T3/es not_active Expired - Lifetime
- 1994-03-07 PL PL94306209A patent/PL180372B1/pl not_active IP Right Cessation
- 1994-03-07 AU AU64446/94A patent/AU666270B2/en not_active Ceased
- 1994-03-07 NZ NZ299913A patent/NZ299913A/en not_active IP Right Cessation
- 1994-03-07 RU RU94046091A patent/RU2114118C1/ru not_active IP Right Cessation
- 1994-03-07 NZ NZ263668A patent/NZ263668A/en unknown
- 1994-03-07 AT AT94912199T patent/ATE167874T1/de not_active IP Right Cessation
- 1994-03-07 DE DE69411342T patent/DE69411342T2/de not_active Expired - Fee Related
- 1994-03-07 UA UA94119008A patent/UA34456C2/uk unknown
- 1994-03-10 HR HR08/031,325A patent/HRP940164B1/xx not_active IP Right Cessation
- 1994-03-14 ZA ZA941767A patent/ZA941767B/xx unknown
- 1994-11-10 NO NO19944293A patent/NO313418B1/no unknown
- 1994-11-15 FI FI945378A patent/FI945378A/fi unknown
- 1994-11-23 EE EE9400166A patent/EE03180B1/xx not_active IP Right Cessation
-
2003
- 2003-03-19 IL IL15499503A patent/IL154995A0/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI9420001B (sl) | Polipeptidni antagonisti bombezina | |
CA2272990A1 (en) | Heptapeptide oxytocin analogues | |
CA2097192A1 (en) | Bombesin antagonists | |
CA1244009A (en) | Lh-rh antagonists | |
GB1533077A (en) | 4-substituted enkephalin derivatives | |
GB1526367A (en) | Polypeptide | |
ES2017028A6 (es) | Procedimiento para preparar antagonistas de bombesina. | |
PT78209B (en) | Gnrh antagonists iii | |
DE2158123A1 (de) | Neue pharmazeutische Präparate | |
DE3267380D1 (en) | Peptides and pseudopeptides in which the n terminus bears two substituents | |
KR920701242A (ko) | 환원된 비가역성 봄베신 길항제 | |
ES416516A1 (es) | Un procedimiento para la preparacion de nonapeptidos. | |
GB1357121A (en) | Peptide enzyme inhibitors | |
ES248724A1 (es) | Procedimiento para la obtenciën de nuevosdecapeptures ciclicos | |
GB1430522A (en) | N-substituted aspartyl peptide amides | |
GB1273873A (en) | Corticotropically highly active octadecapeptides | |
Lübke et al. | The Influence of Substitution or Omission of an Amino Group on the Hypotensive Activity of the C-Terminal Sequences of Eledoisin | |
FR4219M (sl) | ||
GB1037143A (en) | Polypeptides | |
GB1532148A (en) | 1-substituted enkepholin derivatives | |
HRP921277A2 (en) | Nonapeptide bombestin antagonists | |
TH17064B (th) | ตัวปฏิปักษ์ต่อโปลีเปปไทด์บอมเบซิน |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
IF | Valid on the event date | ||
KO00 | Lapse of patent |
Effective date: 20081112 |